Abstract
Introduction

Several studies, in human beings and in animal models, have shown that circulating endothelial progenitor cells (EPCs) are recruited into ischemic tissues
, where they contribute to recovery of perfusion by differentiating into endothelial cells [3] and producing angiogenic factors, thereby enhancing collateral vessel formation [4] . [5, 6] .
Stromal cell derived factor-1 (SDF-1), via phosphoinositide 3-kinase (PI3K)/AKT activation appears to play an important role in EPC function
SDF-1 exerts a chemoattractive function on haematopoietic stem cells [7] and modulates integrin receptors affinity to extracellular matrix components [8] [9] [10] 
. Further, a prior work from our laboratory has shown that SDF-1 induces adhesion-dependent differentiation of bone marrow (BM)-derived c-kit
ϩ progenitors into endothelial cells onto extracellular matrix components as well as their recruitment from the BM in response to acute hindlimb ischemia [11] . [12, 13] , including cardiac and limb ischemia and skin ulcers [14, 15] [12, [16] [17] [18] is impaired. Further, in animal models of streptozotocin (STZ)-induced, type 1-like diabetes [19] , and type 2-like diabetes due to obesity [20] [21] . In addition, in normoglycaemic rats SDF-1 plasma levels increase following acute hindlimb ischemia/reperfusion and this response is abolished in diabetic rats [22] , whereas in diabetic mice SDF-1 expression in skin ulcers is lower than in normoglycaemic controls [23] . In contrast, it has been found a marked increase in SDF-1 mRNA in the mesentery of STZ-treated diabetic rats [24] . 
Patients with type 1 and 2 diabetes mellitus (DM) exhibit impaired new blood vessel development in response to ischemia
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Effect of DM on recovery of perfusion, circulating c-kit ؉ cell number and SDF-1 levels in hindlimb ischemia
Initial experiments were aimed at establishing whether there was a difference in blood flow recovery following acute hindlimb ischemia in normoglycaemic versus DM mice. In agreement with prior studies [19, 28- 
Effects of DM on c-kit ؉ cell differentiation
Diabetes has been reported to inhibit human EPCs differentiation [12, 17] (Fig. S6A-C) . Furthermore, there were no differences in haematopoietic clonogenicity (Fig. S7A (Fig. S7C) . [12] of circulating EPCs and their ability to form endothelial colonies in vitro [17, 40] . This phenomenon, at least in part, may be due to enhancement of oxidative stress related to hyperglycaemia [41] . [6] and that DM impairs some EPCs functions [22, 43] . Similar results have been obtained with EPCs obtained from non-diabetic patients cultured in high glucose conditions [42, 44] . Since SDF-1 binds its receptor CXCR4 and via this mechanism activates PI3K-dependent signalling [37, 45, 46] leading to AKT phosphorylation [47, 48] [6, 11, 22] and EPCs appear to contribute significantly to the angiogenic response to ischemia [1] ; however, EPC function is inhibited in DM [17, 44] . 
01). Post hoc analysis for pairwise comparisons between DM and control animals demonstrated significant differences in perfusion index at day 21 (P Ͻ 0.05) and day 28 (P Ͻ 0.05). Student's t-test showed significant differences at 14, 21 and 28 days after ischemia (P Ͻ 0.05) (C) C-kit ϩ cells in the systemic circulation expressed as% of PB-MNCs. Prior to femoral artery dissection there were more c-kit ϩ cells in normoglycaemic (black bars; n ϭ 12) than in DM (open bars; n ϭ 11) mice (Student's t-test; P Ͻ 0.05). Moreover, after acute ischemia the transient increase in c-kit ϩ cells was more pronounced and sustained in normoglycaemic (n ϭ 8-14 at each time-point) than in DM (n ϭ 8-14 at each time-point) mice (ANOVA P Ͻ 0.01); post hoc analysis for pairwise comparisons demonstrated a significant difference at day 7 (P Ͻ 0.05). PB ckit
In additional experiments, we examined whether the impairment in SDF-1-induced c-kit
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